17.59%F 2.69 25.12%SPY 90.09 1.26%
The Global Business News Leader | Monday, 1 Dec 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- INVESTING
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
ALEXION PHARMACEUTICALS INC.
ALXN (NASDAQ)
$ 0.00 
Change: -33.66 0% | Volume: 1,800
Change: -33.66 0% | Volume: 1,800
Sponsored by 
ALEXION PHARMA - Fundamental Profile
Company Information
| Ticker Symbol: | ALXN |
|---|---|
| Exchange: | NASD |
| Contact Info: | 352 Knotter Drive Cheshire CT 06410 203 272-2596 |
| CEO/President: | Nancy C. Motola Ph.D. |
| Industry: | Medical - Biomedical / Standard Industry Code: 2834 |
| Description: | Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company\'s lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional. |
Share Information
| Shares Outstanding: | 77,800 (000) | Market Value: | 2,642,020 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 92.72% | Number of Inst.Shareholders: | 9.00% |
| Last Quarter Sales: | 76.50 ($Mil.) | Last Quarter Net Income: | 19.69 ($Mil.) |
| Last Quarter EPS: | 0.23 | P/E Ratio: | 849 |
| Most Recent Earnings: | 0.29 on 10/23/08 | Earnings Per Share: | 0.04 |
| Most Recent Split: | 2-1 on 08/25/08 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
ALXN
Companies
IBT
- Shoppers seek deals, buy less on Black Friday
- Uranium stocks poised for surge on TSX
- Black Friday shoppers out in force, but cautious
- Oil ends week on a flat note as OPEC gathers
- RBS to be taken over by British government
- Nov. auto sales dreary, but likely up from Oct.
- The Fed boosted emergency loans to banks and firms
- Daily currency analysis - Nov 29
- Gold Investments Market Update - Citigroup Report: Gold Holders "Mellow" for Years; Holders of Other Asset Classes Increasingly "Yellow"
- Shoppers seek deals, buy less on Black Friday
- Black Friday traffic takes down Sears.com
- Stocks end short session with 5th straight gain
- Dollar Strong No Matter What!
- Appetite for Risk to Dictate Short-Term Direction for the U.S. Dollar
Top Competitors
| AMGEN INC. |  |
+5.60 | 55.54 |
| GILEAD SCIENCES |  |
-9.90 | 44.79 |
| CELGENE CORPORA | |
-21.80 | 52.10 |
| STEMCELLS INC. | |
-52.80 | 1.06 |
| GENENTECH INC | |
-3.20 | 76.60 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives